Cardiac thrombosis, a serious medical condition, refers to the formation of blood clots within the heart's chambers or blood vessels. This phenomenon poses a significant threat to cardiovascular health, as these clots can obstruct blood flow, leading to potentially life-threatening complications such as heart attacks or strokes. The development of cardiac thrombosis is often associated with underlying cardiovascular diseases, such as atrial fibrillation, myocardial infarction, or heart valve disorders. Additionally, individuals with certain risk factors, including obesity, smoking, and a sedentary lifestyle, may be more susceptible to this condition. Timely diagnosis and intervention are crucial in managing cardiac thrombosis. Treatment may involve anticoagulant medications to prevent further clot formation and reduce the risk of adverse events. Patients are typically closely monitored by healthcare professionals to ensure an effective and personalized management plan, emphasizing the importance of lifestyle modifications and ongoing medical care to mitigate the risk of recurrence.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India